24小时热门版块排行榜    

查看: 2555  |  回复: 27
本帖产生 2 个 DRDEPI ,点击这里进行查看
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

狼行拂晓

荣誉版主 (著名写手)

~~~~

[交流] 金秋之际话“丰收”,有奖分享经验总结活动,期待你的参与! 已有10人参与

金秋之际话“丰收”,有奖分享经验总结活动,期待你的参与!


自古逢秋悲寂寥,我言秋日胜春朝。晴空一鹤排云上,便引诗情到碧霄.


秋天,有落叶的凋零,也有硕果的累累……


秋天,有沥沥细雨的凄凄,也有落霞孤鹜齐飞、秋水长天一色的明朗……


秋天,不论景色如何,不论收获如何,总应该将心胸放宽,总应该将目光放远,哪怕是落叶,也是化作春泥。在这个秋天,让我们悉心的总结下过去,展望下未来。只有善于总结,才能有更高远的发展,只有善于总结,才能踏实走好每一段路……



【活动内容】

在这里,让我们总结下上半年或者以前的工作学习中的心得、经验体会。


在这里,让我们畅所欲言;


可以是学习了一篇指导原则分享如何进行杂质的控制经验;


可以是工作学习中掌握的某个经典反应的合成方法;


可以是车间中某个中试放大工艺的操作技巧;


可以是某类药物分析方法的开发思路;


可以是种种工作中的经验体会……


欢迎各位来分享你的心得,分享你的经验总结,金币多多,奖励多多,赶快来参与吧!!大家一起加油来将新药研发版打造成一个更加繁荣的更加利于每一位站友学习交流的板块!




【活动目的】:
       三人行,必有我师焉,互相交流才能共同成长。
【活动时间】:
2015.10.9——2015.12.31
【奖励规定】:
        1.如按活动内容回帖,即可得10-20金币,如内容较充实,对于其他战友的学习成长非常具有参考价值,可奖励20-40金币和1个EPI,具体根据回帖的详细程度和回帖质量综合给出;
     2.其他未尽事宜由版主酌情处理;


[ Last edited by 狼行拂晓 on 2015-10-19 at 20:11 ]
回复此楼
随缘惜缘不攀缘~
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

狼行拂晓

荣誉版主 (著名写手)

~~~~

狼行拂晓: 回帖置顶 2015-11-05 16:49:45
相信论坛里做仿制药的相对多一点,FDA中关于Generic Drug的指导原则这么多,大家都可以就其中一篇发表下学习收获等……
Generic Drug Issued Date
180-Day Exclusivity When Multiple Abbreviated New Drug Applications Are Submitted on the Same Day (I) 8/1/2003
Abbreviated New Drug Applications: Impurities in Drug Products 11/29/2010
Alternate Source of Active Pharmaceutical Ingredients in Pending ANDAs (I) 12/12/2000
ANDAs: Impurities in Drug Substances; Chemistry, Manufacturing and Controls Information (I) 7/15/2009
ANDAs: Pharmaceutical Solid Polymorphism; Chemistry, Manufacturing and Controls Information (I) 7/9/2007
ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers 5/15/2014
ANDA Submissions – Amendments and Easily 7/10/2014
ANDA Submissions – Prior Approval Supplements Under GDUFA 7/10/2014
ANDA Submissions -- Refuse-to-Receive Standards 9/16/2014
Controlled Correspondence Related to Generic Drug Development 8/26/2014
Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman
Amendments to the Federal Food, Drug, and Cosmetic Act (I) 3/30/2000
Handling and Retention of Bioavailability and Bioequivalence Testing Samples (I) 5/26/2004
Individual Product Bioequivalence Recommendations - List of Product Bioequivalence Recommendations (I) 6/11/2010
Letter announcing that the OGD will now accept the ICH long-term storage conditions as well as the stability studies conducted in the past (I)8/18/1995
Letter describing efforts by the CDER & the ORA to clarify the responsibilities of CDER chemistry review scientists and ORA field investigators in the new & abbreviated drug approval process in order to reduce duplication or redundancy in the process (I) 10/14/1994
Letter on incomplete Abbreviated Applications, Convictions Under GDEA, Multiple Supplements,Annual Reports for Bulk Antibiotics, Batch Size for Transdermal Drugs, Bioequivalence Protocols, Research, Deviations from OGD Policy (I) 4/8/1994
Letter on the provision of new information pertaining to new bioequivalence guidelines and refuse-to-file letters (I) 7/1/1992
Letter on the provision of new procedures and policies affecting the generic drug review process (I) 3/15/1989
Letter on the request for cooperation of regulated industry to improve the efficiency and effectiveness of the generic drug review process, by assuring the completeness and accuracy of required information and data submissions (I) 11/8/1991
Letter on the response to 12/20/84 letter from the Pharmaceutical Manufacturers Association about the Drug Price Competition and Patent Term Restoration Act (I) 3/26/1985
Letter to all ANDA and AADA applicants about the Generic Drug Enforcement Act of 1992 (GDEA), and the Office of Generic Drugs intention to refuse-to-file incomplete submissions as required by the new law (I) 1/15/1993
Letter to regulated industry notifying interested parties about important detailed information regarding labeling, scale-up, packaging, minor/major amendment criteria, and bioequivalence requirements (I) 8/4/1993
Major, Minor, and Telephone Amendments to Abbreviated New Drug Applications (I) 12/21/2001
Revising ANDA Labeling Following Revision of the RLD Labeling (I) 4/25/2000
Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules 12/10/2013
Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications (I) 5/6/2011
Variations in Drug Products that May Be Included in a Single ANDA (I) 1/27/1999
随缘惜缘不攀缘~
20楼2015-11-05 16:48:22
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 28 个回答

凌宇雷池

超级版主 (文学泰斗)

小木虫科研大使\(^o^)/~

优秀区长优秀区长优秀区长优秀区长优秀区长优秀版主优秀版主优秀版主

★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
狼行拂晓: 金币+1, 感谢支持,超版也可以带个头分享下撒,O(∩_∩)O~ 2015-10-09 22:28:33
表示支持哈 可以推荐一下帖子 加上高亮\(^o^)/~

» 本帖已获得的红花(最新10朵)

上善若水\(^o^)/~2025\(^o^)/~
2楼2015-10-09 22:23:35
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

News

专家顾问 (职业作家)

★ ★ ★ ★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
狼行拂晓: 金币+8, 感谢支持,感谢建议,活动的气氛也得多仰仗你们这些优秀的老战友啊!可能大家把活动想复杂了吧,其实一两句话能说明白的一个经验都能有大量币币奖励的O(∩_∩)O~ 2015-10-11 11:42:23
支持支持,版内虫友参与积极分享以及讨论的热情不是很高。我觉得需要多举行相关的交流分享活动,联络一群愿意交流分享并为小木虫的新药研发板块良好发展尽微薄之力的虫虫。
版主更应该带头,金币就不要吝啬了。
水滴石穿!!
3楼2015-10-11 09:07:20
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

狼行拂晓

荣誉版主 (著名写手)

~~~~

引用回帖:
4楼: Originally posted by News at 2015-10-11 11:56:11
红花支持。

谢谢!
我楼下举个简单的例子,兄弟跟帖吧。
随缘惜缘不攀缘~
5楼2015-10-11 12:45:41
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 龙 兔 虎 猫 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考博] 27博士 +7 锦鲤送福至 2026-11-10 7/350 2026-11-16 23:03 by Equinoxhua
[考博] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 uKOSCocCb6Fm 2026-11-13 3/150 2026-11-16 10:33 by K7HMGGdOpylw
[考研] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +4 uKOSCocCb6Fm 2026-11-13 4/200 2026-11-16 10:11 by K7HMGGdOpylw
[论文投稿] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +4 SX5mJmPWDfOO 2026-11-13 4/200 2026-11-15 07:45 by xSrQNSSjcgoX
[考研] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 uKOSCocCb6Fm 2026-11-13 3/150 2026-11-15 05:11 by xSrQNSSjcgoX
[考研] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 uKOSCocCb6Fm 2026-11-12 5/250 2026-11-15 03:21 by xSrQNSSjcgoX
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-15 00:27 by Equinoxhua
[考研] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +5 YHiw1gou1Eda 2026-11-10 8/400 2026-11-14 22:51 by Equinoxhua
[教师之家] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +6 C6CRn66RYYXS 2026-11-10 6/300 2026-11-13 04:21 by Equinoxhua
[论文投稿] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +3 TgvkbZZl9tqB 2026-11-11 4/200 2026-11-12 12:51 by ECLTXnJnRSXf
[公派出国] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +3 TgvkbZZl9tqB 2026-11-11 4/200 2026-11-12 12:48 by ECLTXnJnRSXf
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +3 Z7qfCsdIiD1T 2026-11-10 7/350 2026-11-12 11:31 by HajghKOMynmz
[教师之家] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 Z7qfCsdIiD1T 2026-11-10 5/250 2026-11-12 11:14 by HajghKOMynmz
[考博] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +4 czAiolzR0IJC 2026-11-10 7/350 2026-11-12 11:11 by HajghKOMynmz
[公派出国] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 czAiolzR0IJC 2026-11-10 8/400 2026-11-12 11:11 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-12 10:38 by HajghKOMynmz
[考博] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +4 C6CRn66RYYXS 2026-11-10 6/300 2026-11-12 10:27 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +3 C6CRn66RYYXS 2026-11-10 8/400 2026-11-12 10:16 by HajghKOMynmz
[硕博家园] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 C6CRn66RYYXS 2026-11-10 6/300 2026-11-12 10:16 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +4 C6CRn66RYYXS 2026-11-10 6/300 2026-11-12 06:03 by 9fOTqj074tIg
信息提示
请填处理意见